Sarcoma trials in United States
300 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleImplantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
- Where
- Houston
- Age
- 10 years and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04199026 - Phase 1/2Taking peopleSPEARHEAD-3 Pediatric Study
- Where
- Bethesda, Boston, Cincinnati, Durham, Madison, New York, Palo Alto, Philadelphia, Seattle, St Louis
- Age
- 2 years to 21 years
- People
- 20
- Run by
- USWM CT, LLC
See details and how to joinNCT05642455 - Phase 3Taking peopleA Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- Where
- Columbus, Durham, Farmington Hills, Los Angeles, New Haven, Omaha, Philadelphia, Santa Monica
- Age
- 18 years and over
- People
- 333 worldwide
- Run by
- Intensity Therapeutics, Inc.
See details and how to joinNCT06263231 · EU 2024-512423-36-00 - Phase 1/2Taking peopleSafety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
- Where
- Cleveland
- Age
- 12 years and over
- People
- 17
- Run by
- Ankit Mangla, MD
See details and how to joinNCT07549022 - No phaseTaking peopleMolecular Basis of Pediatric Liver Cancer
- Where
- Pittsburgh
- Age
- 0 years to 99 years
- People
- 1,600
- Run by
- University of Pittsburgh
See details and how to joinNCT03959800 - No phaseTaking peopleInternational Rare Brain Tumor Registry
- Where
- Akron, Chicago, Cincinnati, Los Angeles, San Francisco, Washington D.C.
- Age
- Up to 45 years
- People
- 5,800 worldwide
- Run by
- Children's National Research Institute
See details and how to joinNCT05697874 - Phase 1Taking peopleInterleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Where
- Houston
- Age
- 1 year to 21 years
- People
- 24
- Run by
- Baylor College of Medicine
See details and how to joinNCT04715191 - Phase 1Taking peopleDisulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Where
- Cleveland
- Age
- 18 years and over
- People
- 24
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT05210374 - No phaseTaking peopleMusculoskeletal Cancers Remote Monitoring and Care
- Where
- Cleveland
- Age
- 18 years and over
- People
- 60
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT07129226 - Phase 1Taking peopleA Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
- Where
- Houston
- Age
- 1 year to 30 years
- People
- 18
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07444619 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Houston, San Antonio, St Louis
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - No phaseEnrolling by invitationA Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy
- Where
- Basking Ridge, Commack, East White Plains, Middletown, Montvale, New York, Uniondale
- People
- 250
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06113315 - No phaseTaking peopleEvaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
- Where
- Rochester
- Age
- 18 years and over
- People
- 75
- Run by
- Mayo Clinic
See details and how to joinNCT06409013 - Phase 1/2Taking peopleNRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Where
- Atlanta, Baton Rouge, Boston, Chicago, Cincinnati, Memphis, St Louis
- Age
- Up to 30 years
- People
- 139
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06239272 - Phase 1/2Taking peopleProton or Photon RT for Retroperitoneal Sarcomas
- Where
- Boston, Buffalo, Chicago, Creve Coeur, Durham, Houston, Rochester, Salt Lake City, St Louis
- Age
- 18 years and over
- People
- 80
- Run by
- Massachusetts General Hospital
See details and how to joinNCT01659203 - Early phase 1Taking peopleFeasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Where
- Orange
- Age
- 18 years and over
- People
- 25
- Run by
- University of California, Irvine
See details and how to joinNCT07628634 - Phase 1Taking peopleA Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy
- Where
- Houston
- Age
- 18 years and over
- People
- 15
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07633756 - No phaseTaking peopleNovel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- People
- 3,000
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT00579566 - Phase 1Taking peoplePhase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
- Where
- Houston
- Age
- 16 years to 80 years
- People
- 44
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06083883 - Phase 2Taking peopleAbemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
- Where
- Iowa City, Jacksonville, Milwaukee, St Louis
- Age
- 18 years and over
- People
- 44
- Run by
- Medical College of Wisconsin
See details and how to joinNCT04040205 - Phase 2Taking peopleA Study of Pembrolizumab in People With Ultra-Rare Sarcomas
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 32
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07089992 - Phase 1/2Taking peopleEarly Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
- Where
- Dallas, Washington D.C.
- Age
- 18 years and over
- People
- 45
- Run by
- AeRang Kim
See details and how to joinNCT06735820 - Phase 2Taking peopleMetformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
- Where
- Charlotte, Winston-Salem
- Age
- 18 years and over
- People
- 50
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07291297 - Phase 1Taking peoplePhase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
- Where
- Fairfax, Los Angeles, New Haven, New York, Sarasota, St Louis
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT07374848 - No phaseNot yet taking people in United StatesWeb-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial
- Where
- Columbus
- Age
- 40 years to 69 years
- People
- 90
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07723235